Last10K.com

Healthy Extracts Inc. (HYEX) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

HYEX Quarterly Reports

Healthy Extracts Inc.

CIK: 1630176 Ticker: HYEX
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 12, 2022
Details  
Registrant CIK0001630176 
Fiscal Year End--12-31 
Document Type10-Q 
Document Quarterly Reporttrue 
Document Period End DateMar. 31, 2022 
Document Transition Reportfalse 
Entity File Number000-55572 
Entity Registrant NameHealthy Extracts Inc. 
Entity Incorporation, State or Country CodeNV 
Entity Tax Identification Number47-2594704 
Entity Address, Address Line One1 Silvermound 
Entity Address, City or TownLittleton 
Entity Address, State or ProvinceCO 
Entity Address, Postal Zip Code80127 
Country Region720 
City Area Code463 
Local Phone Number1004 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Entity Ex Transition Periodfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 338,091,821
Amendment Flagfalse 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ1 

View differences made from one quarter to another to evaluate Healthy Extracts Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Healthy Extracts Inc..

Continue

Assess how Healthy Extracts Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Healthy Extracts Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets - Parenthetical
Consolidated Statement Of Operations
Consolidated Statements Of Changes In Stockholders' Equity (Deficit)
Statements Of Cash Flows
Note 1 - Organization And Description Of Business
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies: Accounts Receivables (Policies)
Note 2 - Summary Of Significant Accounting Policies: Basis Of Presentation (Policies)
Note 2 - Summary Of Significant Accounting Policies: Cash (Policies)
Note 2 - Summary Of Significant Accounting Policies: Common Stock Purchase Warrants (Policies)
Note 2 - Summary Of Significant Accounting Policies: Concentration (Policies)
Note 2 - Summary Of Significant Accounting Policies: Convertible Instruments (Details)
Note 2 - Summary Of Significant Accounting Policies: Convertible Instruments (Policies)
Note 2 - Summary Of Significant Accounting Policies: Fair Value Measurements (Policies)
Note 2 - Summary Of Significant Accounting Policies: Fair Value Measurements: Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis (Details)
Note 2 - Summary Of Significant Accounting Policies: Fair Value Measurements: Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis (Tables)
Note 2 - Summary Of Significant Accounting Policies: Goodwill (Policies)
Note 2 - Summary Of Significant Accounting Policies: Income Taxes (Policies)
Note 2 - Summary Of Significant Accounting Policies: Indefinite-Lived Intangible Assets (Details)
Note 2 - Summary Of Significant Accounting Policies: Indefinite-Lived Intangible Assets (Policies)
Note 2 - Summary Of Significant Accounting Policies: Inventory (Details)
Note 2 - Summary Of Significant Accounting Policies: Inventory (Policies)
Note 2 - Summary Of Significant Accounting Policies: Property And Equipment (Policies)
Note 2 - Summary Of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)
Note 2 - Summary Of Significant Accounting Policies: Revenue Recognition (Policies)
Note 2 - Summary Of Significant Accounting Policies: Use Of Estimates (Policies)
Note 3 - Going Concern
Note 3 - Going Concern (Details)
Note 4 - Related Party
Note 4 - Related Party (Details)
Note 5 - Notes Payable
Note 5 - Notes Payable (Details)
Note 5 - Notes Payable: Schedule Of Debt (Details)
Note 5 - Notes Payable: Schedule Of Debt (Tables)
Note 6 - Convertible Debt
Note 6 - Convertible Debt (Details)
Note 6 - Convertible Debt: Convertible Debt (Details)
Note 6 - Convertible Debt: Convertible Debt (Tables)
Note 6 - Convertible Debt: Schedule Of Convertible Debt 2 (Details)
Note 6 - Convertible Debt: Schedule Of Convertible Debt 2 (Tables)
Note 7 - Stockholders' Equity
Note 7 - Stockholders' Equity (Details)
Note 8 - Business Segment Information
Note 8 - Business Segment Information: Schedule Of Segment Reporting Information, By Segment (Details)
Note 8 - Business Segment Information: Schedule Of Segment Reporting Information, By Segment (Tables)
Note 9 - Subsequent Events

Material Contracts, Statements, Certifications & more

Healthy Extracts Inc. provided additional information to their SEC Filing as exhibits

Ticker: HYEX
CIK: 1630176
Form Type: 10-Q Quarterly Report
Accession Number: 0001096906-22-001150
Submitted to the SEC: Mon May 16 2022 4:32:26 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Computer Processing And Data Preparation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/hyex/0001096906-22-001150.htm